Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 11 of 11

List	Outcome	Time frame
Primary	The mean change in the PANSS Total Score	from baseline to Week 6
Primary	The percentage of patients showing significant weight gain (a≥ 7% increase)	from baseline to Week 26
Secondary	Change from baseline on the CGI-S Score	at the end of study
Secondary	Change from baseline on PANSS Total Score	at the end of study
Secondary	Change from baseline on PANSS-Positive Scale Total Score	at the end of study
Secondary	Change from baseline on PANSS-Negative Scale Total Score	at the end of study
Secondary	Mean change from baseline in PANSS-derived Brief Psychiatric Rating Scale (BPRS) Core Score	at the end of study
Secondary	Mean CGI-I Score	at the end of study
Secondary	Percentage of responders (≥ 30% decrease in PANSS Total Score, or score of 1 or 2 on CGI-I)	at the end of study
Secondary	Change from baseline on the MADRS	at the end of study
Secondary	Safety and tolerability	at the end of study

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00712686/registered